Patents Examined by Barbara Frazier
-
Patent number: 8568749Abstract: Systems and methods for skin rejuvenation are disclosed herein. In an embodiment, a skin rejuvenation system includes a unit dose of a booster product that includes active ingredients of ferulic acid and phloretin; a unit dose of at least one exfoliating product that includes active ingredients of ferulic acid and phloretin in combination with fruit acids or alpha hydroxyacids; and a unit dose of a nano-additive product for enhancing penetration of the active ingredients. A method for skin rejuvenation includes applying topically, to a skin surface to be treated, a booster product including active ingredients of ferulic acid and phloretin; applying topically, to the skin surface, at least one exfoliating product including active ingredients of ferulic acid and phloretin in combination with one of fruit acids or alpha hydroxyacids; and applying topically, to the skin surface, a nano-additive product for enhancing penetration of the active ingredients.Type: GrantFiled: April 2, 2010Date of Patent: October 29, 2013Assignee: Sesvalia USA, LLCInventors: Gabriel Serrano Sanmiguel, Juan Manuel Serrano Nuñez, Joaquin Melendez Zamora
-
Patent number: 8557269Abstract: A paper tissue and products made from paper tissue, such as paper handkerchiefs, facial tissues, bath and cosmetic tissues, paper tissue wipes of any kinds and the like. The invention describes both the process for making a smooth and absorbent lotioned paper tissue, with high transferability of the lotion. The process steps comprises the steps of (a) providing a paper tissue web continuously moving next to a lotion application unit comprising at least one rotating surface, (b) transferring said lotion onto one rotating surface,’(c) expulsing said lotion from the said rotating surface into a stream of lotion droplets, by primarily the centrifugal force of the rotation of said rotating surface, (d) intercepting said paper tissue with said stream of lotion droplets. The invention also describes a paper tissue comprising a lotion distributed as discrete deposits on its surface. The deposits have a high local concentration of lotion and cover a relatively small area of the tissue.Type: GrantFiled: April 14, 2005Date of Patent: October 15, 2013Assignee: The Procter & Gamble CompanyInventors: Joerg Kleinwaechter, Dirk Butz, Curtis Allen Marcott, Luigi Di Girolamo
-
Patent number: 8512680Abstract: The placing of a drug that is suitable for parenteral administration on bubbles formed with sterile gases produces an exponential increase in its active surface area with a decrease in the diameter of the bubble, modifies the kinetics of its distribution and, thanks to its micronization, increases its therapeutic effect. Furthermore, the echogenicity of the bubbles allows us to follow them on ultrasound after their injection, so that we can visualise the medicament and, thanks to its steerability, can direct it to the selected site or prevent it from reaching undesired areas. This pharmaceutical form is of interest in the treatment of diseases that require a greater local action of the injected drugs than can be achieved with the pharmaceutical forms in current use.Type: GrantFiled: July 16, 2007Date of Patent: August 20, 2013Assignee: BTG International Ltd.Inventor: María Antonia García-Olmedo Dominguez
-
Patent number: 8475818Abstract: The present invention provides formulations and methods useful in the control of ectoparasites on a domestic animal, using a formulation comprising Indoxacarb and a veterinarily acceptable carrier that is applied topically to 10% or less of the total surface area of a domestic animal. Other embodiments include these formulations also including one or more additional pesticides such as fipronil.Type: GrantFiled: August 30, 2007Date of Patent: July 2, 2013Assignee: E. I. de Pont de Nemours and CompanyInventors: Frank Guerino, Keith Alan Freehauf, Roger Mervyn Sargent, Peter Andrew O'Neil, Robert D. Simmons, Chen-Chao Wang
-
Patent number: 8461349Abstract: What are described are novel active compound combinations comprising a known oxime ether derivative (trifloxystrobin) and imidacloprid, which combinations are highly suitable for controlling phytopathogenic fungi and insects.Type: GrantFiled: December 19, 2011Date of Patent: June 11, 2013Assignee: Bayer CropScience AGInventors: Ulrike Wachendorff-Neumann, Astrid Mauler-Machnik, Hirohisa Ohtake, Angelika Lubos-Erdelen
-
Patent number: 8425885Abstract: Certain novel substituted 3-(phenoxymethyl) benzyl amines and personal care compositions comprising such, which are particularly beneficial for skin lightening and achieving evenness of color, especially for face and underarm skin.Type: GrantFiled: November 9, 2009Date of Patent: April 23, 2013Assignee: Conopco, Inc.Inventors: Jose Guillermo Rosa, Bijan Harichian, John Steven Bajor, Carol Annette Bosko, Diana Jean Drennan, John Chun-Sing Nip
-
Patent number: 8413666Abstract: A method to gently and permanently relax or straighten hair utilizes a protease enzyme, and preferably the enzyme kerA. The hair is optionally treated with a swelling agent, after which it is treated with the enzyme in an aqueous solution. The hair is then physically manipulated, such as by ironing, to remove unwanted curl, wave, and or kink. The enzyme has the ability to cleave inter-peptide bonds, allowing the hair fiber to be relaxed or straightened with less damage to the fiber than would have occurred using traditional or existing straightening methods.Type: GrantFiled: July 15, 2009Date of Patent: April 9, 2013Assignee: Beilis Development, LLCInventor: Richard A. Presti
-
Patent number: 8399522Abstract: The present invention pertains to a method of counteracting a malodor by introducing a malodor counteracting effective amount of a novel 3.2.Type: GrantFiled: October 8, 2010Date of Patent: March 19, 2013Assignee: International Flavors & Fragrances IncInventors: Benjamin Amorelli, Johan Gerwin Lodewijk Pluyter, Adam P. Closson
-
Patent number: 8388938Abstract: The present invention provides a solid, oral tooth whitening confectionary composition comprising a tooth whitening agent comprising an alkaline or alkaline earth metal pyrophosphate, preferably calcium pyrophosphate. In one embodiment, the composition of the invention comprises an additional tooth whitening agent.Type: GrantFiled: December 8, 2004Date of Patent: March 5, 2013Assignee: Cadbury Holdings LimitedInventor: Edith Sorensen
-
Patent number: 8389768Abstract: Provided herein are novel cationic lipids, compositions comprising the cationic lipids, and methods of using the cationic lipids. In some claims, the cationic lipids have cytotoxic activity and can be used alone or in combination with a cytotoxic bioactive compound to kill a cell. In some of these claims, the cationic lipid enhances the cytotoxic activity of the cytotoxic bioactive compound. Methods for treating a subject afflicted with a disease or unwanted condition are provided, wherein the method comprises administering a delivery system comprising a novel cationic lipid to the subject. The invention further provides methods for making delivery systems comprising the novel cationic lipids of the invention.Type: GrantFiled: May 1, 2009Date of Patent: March 5, 2013Assignee: The University of North Carolina at Chapel HillInventors: Leaf Huang, Yunching Chen, Joyeeta Sen, Surendar Reddy Bathula, Sumio Chono, Shyh-Dar Li, Michael Hackett
-
Patent number: 8388992Abstract: A disposable paper towel with an anti-microbial lotion and is provided with a chromatic transfer indicator which undergoes a delayed, visually perceptible color change at a predetermined time after the towel is wetted. An anti-microbial lotion on the towel increases water absorbency times (WAR) to further promote lotion transfer to the skin and increase lotion transfer effectiveness.Type: GrantFiled: March 26, 2007Date of Patent: March 5, 2013Assignee: Georgia-Pacific Consumer Products LPInventors: Phuong Van Luu, Anthony O. Awofeso, Craig D. Yardley, Kang Chang Yeh, Bruce W. Janda
-
Patent number: 8377465Abstract: The present invention provides feed or food products for consumption by animals or humans which include respective quantities of flax oil and non-flax carbohydrate. The flax oil and carbohydrate are mixed together and simultaneously subjected to an elevated temperature of at least about 120° F. and subsequently cooled; the flax oil is used at a level so that the final product contains at least about 5% by weight flax oil. It has been found that the products of the invention, when fed at effective levels, induce increased in vivo synthesis of desirable eicosapentaenoic acid (EPA).Type: GrantFiled: February 11, 2005Date of Patent: February 19, 2013Assignee: Kansas State University Research FoundationInventor: James S. Drouillard
-
Patent number: 8309109Abstract: A cosmetic in an emulsified state, in which a titanium dioxide microparticle coated with hydrous silicic acid and/or a hydrous silicate compound, a higher alcohol, an oily component other than the higher alcohol, and a polysaccharide are contained, and the polysaccharide containing at least one of fucose, glucose, glucuronic acid and rhamnose as a constituent monosaccharide, and having fucose and/or rhamnose in a side chain is contained in an amount of 0.01% by weight to 1% by weight relative to the total amount of the cosmetic. And a cosmetic containing the higher alcohol, the oily component and the polysaccharide in an emulsified state, in which the higher alcohol is composed of two or more kinds of higher alcohols having different molecular weights, and is contained in the cosmetic in an amount of 1% by weight to 20% by weight relative to the total amount of the cosmetic.Type: GrantFiled: June 29, 2007Date of Patent: November 13, 2012Assignees: Hakuto Co., Ltd., Kanagawa UniversityInventors: Kazuo Tajima, Yoko Imai, Teruo Horiuchi, Yasuhiro Nohata
-
Patent number: 8309608Abstract: The present invention relates to the use of compounds which enhance the transcription of endothelial nitric oxide synthase (eNOS) for treating stem and progenitor cells in the cell therapy of patients with ischemic heart diseases such as coronary heart disease or ischemic cardiomyopathy. Treatment of such cells which are isolated from bone marrow, for example, with an eNOS transcription enhancer prior to their administration improves their functional activity and ameliorates neovascularization of the heart and cardiac regeneration.Type: GrantFiled: November 2, 2004Date of Patent: November 13, 2012Assignee: Sanofi-Aventis Deutschland GmbHInventors: Andreas Zeiher, Stefanie Dimmeler, Christopher Heeschen, Hartmut Ruetten
-
Patent number: 8309117Abstract: The present invention provides a method for preparing a medical device, preferably a contact lens, having an antimicrobial metal-containing LbL coating on a medical device, wherein the antimicrobial metal-containing LbL coating comprises at least one layer of a negatively charged polyionic material having —COOAg groups and/or silver nanoparticles formed by reducing Ag+ ions associated with the —COO? groups of the negatively charged polyionic material. In addition, the present invention provides a medical device prepared according to a method of the invention.Type: GrantFiled: December 10, 2003Date of Patent: November 13, 2012Assignee: Novartis, AGInventors: Michael F. Rubner, Sung Yun Yang, Yongxing Qiu, Lynn Cook Winterton, John Martin Lally
-
Patent number: 8263109Abstract: According to an aspect of the invention, injectable bulking compositions are provided which contain the following: (a) fibers that are configured to prevent migration to locations in the body remote from the injection site, for example, because they have a minimum length that is sufficiently large to prevent migration of the fibers and/or because they have surface features that stimulate host tissue response to lock the fibers in position and (b) a carrier in an amount effective to render the composition injectable.Type: GrantFiled: May 9, 2005Date of Patent: September 11, 2012Assignee: Boston Scientific Scimed, Inc.Inventors: Jamie Li, Michael Madden
-
Patent number: 8247405Abstract: Skin lightening additives and skin lightening compositions having an acetylcholinesterase inhibitor are described. The compositions are suitable for topical application and may comprise inhibitors like galanthamine, taspine or both.Type: GrantFiled: December 10, 2008Date of Patent: August 21, 2012Assignee: Conopco, Inc.Inventor: Stephen Alan Madison
-
Patent number: 8232417Abstract: The present invention discloses certain derivatives of artemisinin and the active principles contained in Artemisia annua extracts with amino acids, peptides, and amino sugars and salts thereof (formula I).Type: GrantFiled: April 5, 2012Date of Patent: July 31, 2012Assignee: Bioderm ResearchInventor: Shyam K Gupta
-
Patent number: 8211318Abstract: A biocide is formed by mixing at least one of ammonium sulfamate and ammonium carbamate with an aqueous solution of a hypochlorite oxidant at a molar ratio of ammonium to hypochlorite of at least 1:1. The biocide is useful in treating microbial or biofilm growth, pulp and paper process water, cooling tower water, waste water, reclaimed waste water, sludge, colloidal suspensions, irrigation water or a medium having a reducing capacity.Type: GrantFiled: August 20, 2010Date of Patent: July 3, 2012Assignee: A. Y. Laboratories LtdInventor: Ayala Barak
-
Patent number: 8211449Abstract: A topical pharmaceutical aerosol foam containing liquid silicones to enhance cosmetic elegance. Although liquid silicones are inherent defoamers, a high quality, stable foam is produced.Type: GrantFiled: June 24, 2004Date of Patent: July 3, 2012Assignee: DPT Laboratories, Ltd.Inventors: Duncan T. Aust, David P. Jones, Bhavesh P. Shah